Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CRISPR Therapeutics

Explore full profile

Gene-based medicines for patients with serious diseases

SwitzerlandFounded 2013Biotech & Life Sciences
Valuation $3.07B Market cap · Aug/2026
Revenue $40M Latest reported FY

At a glance

Status
Listed
Founded
2013
Headquarters
Switzerland
Listing
IPO 2016
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News ARK pours $17M into Cerebras, exits AMD and Palantir Sep 9, 2026 Market map Computational Biology & Chemistry startups in Europe

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later14 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 344 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 21 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former CRISPR Therapeutics employees who went on to found companies, sorted by Dealroom signal score.

Zag BioEst. 2022
JKJohn KulmanUnited States
Signal score92
Clade TherapeuticsEst. 2020
Chad CowanUnited States
Signal score62
Vernal BiosciencesEst. 2021
Christian CobaughUnited States
Signal score60
AirNexis TherapeuticsEst. 2025
Maria FardisUnited States
Signal score56
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇺🇸 United States97.6%
🇨🇦 Canada1.1%
🇬🇧 United Kingdom0.3%
🇮🇳 India0.3%
🇧🇪 Belgium0.3%
Top 5 of 6 shown
Web traffic by country
120K monthly visits
across markets
🇺🇸 United States40.3%
🇮🇩 Indonesia5.1%
🇨🇦 Canada4.7%
🇦🇺 Australia4.3%
🇮🇳 India3.8%
Top 5 markets shown

Patents

Estimated portfolio value
$112M

109 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CRISPR Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CRISPR Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles